ID   KCC1A_HUMAN             Reviewed;         370 AA.
AC   Q14012; Q3KPF6;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   12-APR-2017, entry version 176.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase type 1;
DE            EC=2.7.11.17;
DE   AltName: Full=CaM kinase I;
DE            Short=CaM-KI;
DE   AltName: Full=CaM kinase I alpha;
DE            Short=CaMKI-alpha;
GN   Name=CAMK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PHOSPHORYLATION AT THR-177, MUTAGENESIS OF
RP   LYS-49 AND THR-177, AND ENZYME REGULATION.
RX   PubMed=7641687;
RA   Haribabu B., Hook S.S., Selbert M.A., Goldstein E.G., Tomhave E.D.,
RA   Edelman A.M., Snyderman R., Means A.R.;
RT   "Human calcium-calmodulin dependent protein kinase I: cDNA cloning,
RT   domain structure and activation by phosphorylation at threonine-177 by
RT   calcium-calmodulin dependent protein kinase I kinase.";
RL   EMBO J. 14:3679-3686(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 1-9.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [4]
RP   PHOSPHORYLATION BY CAMKK1.
RX   PubMed=9662074; DOI=10.1007/BF02258368;
RA   Hsu L.-S., Tsou A.-P., Chi C.-W., Lee C.-H., Chen J.-Y.;
RT   "Cloning, expression and chromosomal localization of human
RT   Ca2+/calmodulin-dependent protein kinase kinase.";
RL   J. Biomed. Sci. 5:141-149(1998).
RN   [5]
RP   FUNCTION IN PHOSPHORYLATION OF HDAC5.
RX   PubMed=11114197; DOI=10.1073/pnas.260501497;
RA   McKinsey T.A., Zhang C.-L., Olson E.N.;
RT   "Activation of the myocyte enhancer factor-2 transcription factor by
RT   calcium/calmodulin-dependent protein kinase-stimulated binding of 14-
RT   3-3 to histone deacetylase 5.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14400-14405(2000).
RN   [6]
RP   PHOSPHORYLATION BY CAMKK2.
RX   PubMed=11395482; DOI=10.1074/jbc.M011720200;
RA   Hsu L.-S., Chen G.-D., Lee L.-S., Chi C.-W., Cheng J.-F., Chen J.-Y.;
RT   "Human Ca2+/calmodulin-dependent protein kinase kinase beta gene
RT   encodes multiple isoforms that display distinct kinase activity.";
RL   J. Biol. Chem. 276:31113-31123(2001).
RN   [7]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12193581; DOI=10.1210/en.2001-211359;
RA   Condon J.C., Pezzi V., Drummond B.M., Yin S., Rainey W.E.;
RT   "Calmodulin-dependent kinase I regulates adrenal cell expression of
RT   aldosterone synthase.";
RL   Endocrinology 143:3651-3657(2002).
RN   [8]
RP   FUNCTION IN PHOSPHORYLATION OF EIF4G3.
RX   PubMed=14507913; DOI=10.1074/jbc.M308781200;
RA   Qin H., Raught B., Sonenberg N., Goldstein E.G., Edelman A.M.;
RT   "Phosphorylation screening identifies translational initiation factor
RT   4GII as an intracellular target of Ca(2+)/calmodulin-dependent protein
RT   kinase I.";
RL   J. Biol. Chem. 278:48570-48579(2003).
RN   [9]
RP   FUNCTION IN CYCLIN-D1/CDK4 COMPLEX, AND MUTAGENESIS OF LYS-49.
RX   PubMed=14754892; DOI=10.1074/jbc.M312543200;
RA   Kahl C.R., Means A.R.;
RT   "Regulation of cyclin D1/Cdk4 complexes by calcium/calmodulin-
RT   dependent protein kinase I.";
RL   J. Biol. Chem. 279:15411-15419(2004).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH MARK2.
RX   PubMed=17442826; DOI=10.1523/JNEUROSCI.0725-07.2007;
RA   Uboha N.V., Flajolet M., Nairn A.C., Picciotto M.R.;
RT   "A calcium- and calmodulin-dependent kinase Ialpha/microtubule
RT   affinity regulating kinase 2 signaling cascade mediates calcium-
RT   dependent neurite outgrowth.";
RL   J. Neurosci. 27:4413-4423(2007).
RN   [11]
RP   FUNCTION IN HIPPOCAMPAL DENDRITITE GROWTH, AND TISSUE SPECIFICITY.
RX   PubMed=17056143; DOI=10.1016/j.neures.2006.09.013;
RA   Kamata A., Sakagami H., Tokumitsu H., Owada Y., Fukunaga K., Kondo H.;
RT   "Spatiotemporal expression of four isoforms of Ca2+/calmodulin-
RT   dependent protein kinase I in brain and its possible roles in
RT   hippocampal dendritic growth.";
RL   Neurosci. Res. 57:86-97(2007).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATION OF ARHGEF7/BETAPIX, AND INTERACTION WITH
RP   ARHGEF7/BETAPIX AND GIT1.
RX   PubMed=18184567; DOI=10.1016/j.neuron.2007.11.016;
RA   Saneyoshi T., Wayman G., Fortin D., Davare M., Hoshi N., Nozaki N.,
RA   Natsume T., Soderling T.R.;
RT   "Activity-dependent synaptogenesis: regulation by a CaM-kinase
RT   kinase/CaM-kinase I/betaPIX signaling complex.";
RL   Neuron 57:94-107(2008).
RN   [13]
RP   FUNCTION IN AXON ELONGATION.
RX   PubMed=20181577; DOI=10.1523/JNEUROSCI.5984-09.2010;
RA   Neal A.P., Molina-Campos E., Marrero-Rosado B., Bradford A.B.,
RA   Fox S.M., Kovalova N., Hannon H.E.;
RT   "CaMKK-CaMKI signaling pathways differentially control axon and
RT   dendrite elongation in cortical neurons.";
RL   J. Neurosci. 30:2807-2809(2010).
RN   [14]
RP   REVIEW.
RX   PubMed=11749376; DOI=10.1021/cr0002386;
RA   Soderling T.R., Stull J.T.;
RT   "Structure and regulation of calcium/calmodulin-dependent protein
RT   kinases.";
RL   Chem. Rev. 101:2341-2352(2001).
RN   [15]
RP   REVIEW ON FUNCTION IN NEURONAL PLASTICITY.
RX   PubMed=18817731; DOI=10.1016/j.neuron.2008.08.021;
RA   Wayman G.A., Lee Y.S., Tokumitsu H., Silva A.J., Silva A.,
RA   Soderling T.R.;
RT   "Calmodulin-kinases: modulators of neuronal development and
RT   plasticity.";
RL   Neuron 59:914-931(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   REVIEW ON INVOLVEMENT IN CELL CYCLE.
RX   PubMed=21301225; DOI=10.4161/cc.10.4.14798;
RA   Skelding K.A., Rostas J.A., Verrills N.M.;
RT   "Controlling the cell cycle: the role of calcium/calmodulin-stimulated
RT   protein kinases I and II.";
RL   Cell Cycle 10:631-639(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [19]
RP   UBIQUITINATION AT LYS-59.
RX   PubMed=23707388; DOI=10.1016/j.cellsig.2013.05.012;
RA   Mallampalli R.K., Kaercher L., Snavely C., Pulijala R., Chen B.B.,
RA   Coon T., Zhao J., Agassandian M.;
RT   "Fbxl12 triggers G1 arrest by mediating degradation of calmodulin
RT   kinase I.";
RL   Cell. Signal. 25:2047-2059(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-315 IN COMPLEXES WITH ATP,
RP   DOMAIN, AND ENZYME REGULATION.
RX   PubMed=23028635; DOI=10.1371/journal.pone.0044828;
RA   Zha M., Zhong C., Ou Y., Han L., Wang J., Ding J.;
RT   "Crystal structures of human CaMKIalpha reveal insights into the
RT   regulation mechanism of CaMKI.";
RL   PLoS ONE 7:E44828-E44828(2012).
RN   [22]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-217 AND LYS-361.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase that
CC       operates in the calcium-triggered CaMKK-CaMK1 signaling cascade
CC       and, upon calcium influx, regulates transcription activators
CC       activity, cell cycle, hormone production, cell differentiation,
CC       actin filament organization and neurite outgrowth. Recognizes the
CC       substrate consensus sequence [MVLIF]-x-R-x(2)-[ST]-x(3)-[MVLIF].
CC       Regulates axonal extension and growth cone motility in hippocampal
CC       and cerebellar nerve cells. Upon NMDA receptor-mediated Ca(2+)
CC       elevation, promotes dendritic growth in hippocampal neurons and is
CC       essential in synapses for full long-term potentiation (LTP) and
CC       ERK2-dependent translational activation. Downstream of NMDA
CC       receptors, promotes the formation of spines and synapses in
CC       hippocampal neurons by phosphorylating ARHGEF7/BETAPIX on 'Ser-
CC       694', which results in the enhancement of ARHGEF7 activity and
CC       activation of RAC1. Promotes neuronal differentiation and neurite
CC       outgrowth by activation and phosphorylation of MARK2 on 'Ser-91',
CC       'Ser-92', 'Ser-93' and 'Ser-294'. Promotes nuclear export of HDAC5
CC       and binding to 14-3-3 by phosphorylation of 'Ser-259' and 'Ser-
CC       498' in the regulation of muscle cell differentiation. Regulates
CC       NUMB-mediated endocytosis by phosphorylation of NUMB on 'Ser-276'
CC       and 'Ser-295'. Involved in the regulation of basal and estrogen-
CC       stimulated migration of medulloblastoma cells through
CC       ARHGEF7/BETAPIX phosphorylation (By similarity). Is required for
CC       proper activation of cyclin-D1/CDK4 complex during G1 progression
CC       in diploid fibroblasts. Plays a role in K(+) and ANG2-mediated
CC       regulation of the aldosterone synthase (CYP11B2) to produce
CC       aldosterone in the adrenal cortex. Phosphorylates EIF4G3/eIF4GII.
CC       In vitro phosphorylates CREB1, ATF1, CFTR, MYL9 and SYN1/synapsin
CC       I. {ECO:0000250, ECO:0000269|PubMed:11114197,
CC       ECO:0000269|PubMed:12193581, ECO:0000269|PubMed:14507913,
CC       ECO:0000269|PubMed:14754892, ECO:0000269|PubMed:17056143,
CC       ECO:0000269|PubMed:17442826, ECO:0000269|PubMed:18184567,
CC       ECO:0000269|PubMed:20181577}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin results in conformational change that relieves
CC       intrasteric autoinhibition and allows phosphorylation of Thr-177
CC       within the activation loop by CaMKK1 or CaMKK2. Phosphorylation of
CC       Thr-177 results in several fold increase in total activity. Unlike
CC       CaMK4, is unable to exhibit autonomous activity after
CC       Ca(2+)/calmodulin activation. {ECO:0000269|PubMed:23028635,
CC       ECO:0000269|PubMed:7641687}.
CC   -!- SUBUNIT: Monomer. Interacts with XPO1 (By similarity). Interacts
CC       with MARK2, ARHGEF7/BETAPIX and GIT1. {ECO:0000250,
CC       ECO:0000269|PubMed:17442826, ECO:0000269|PubMed:18184567}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}. Note=Predominantly cytoplasmic. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed in cells of the
CC       zona glomerulosa of the adrenal cortex.
CC       {ECO:0000269|PubMed:12193581, ECO:0000269|PubMed:17056143}.
CC   -!- DOMAIN: The autoinhibitory domain overlaps with the calmodulin
CC       binding region and interacts in the inactive folded state with the
CC       catalytic domain as a pseudosubstrate.
CC       {ECO:0000269|PubMed:23028635}.
CC   -!- PTM: Phosphorylated by CaMKK1 and CaMKK2 on Thr-177.
CC       {ECO:0000269|PubMed:11395482, ECO:0000269|PubMed:7641687,
CC       ECO:0000269|PubMed:9662074}.
CC   -!- PTM: Polybiquitinated by the E3 ubiquitin-protein ligase complex
CC       SCF(FBXL12), leading to proteasomal degradation.
CC       {ECO:0000269|PubMed:23707388}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L41816; AAA99458.1; -; mRNA.
DR   EMBL; BC106754; AAI06755.1; -; mRNA.
DR   EMBL; BC106755; AAI06756.1; -; mRNA.
DR   CCDS; CCDS2582.1; -.
DR   PIR; S57347; S57347.
DR   RefSeq; NP_003647.1; NM_003656.4.
DR   UniGene; Hs.434875; -.
DR   PDB; 4FG7; X-ray; 2.70 A; A=1-293.
DR   PDB; 4FG8; X-ray; 2.20 A; A/B=1-315.
DR   PDB; 4FG9; X-ray; 2.40 A; A/B=1-320.
DR   PDB; 4FGB; X-ray; 2.60 A; A=1-320.
DR   PDBsum; 4FG7; -.
DR   PDBsum; 4FG8; -.
DR   PDBsum; 4FG9; -.
DR   PDBsum; 4FGB; -.
DR   ProteinModelPortal; Q14012; -.
DR   SMR; Q14012; -.
DR   BioGrid; 114106; 29.
DR   DIP; DIP-41906N; -.
DR   IntAct; Q14012; 5.
DR   MINT; MINT-201810; -.
DR   STRING; 9606.ENSP00000256460; -.
DR   BindingDB; Q14012; -.
DR   ChEMBL; CHEMBL2493; -.
DR   GuidetoPHARMACOLOGY; 1952; -.
DR   iPTMnet; Q14012; -.
DR   PhosphoSitePlus; Q14012; -.
DR   BioMuta; CAMK1; -.
DR   DMDM; 3122301; -.
DR   EPD; Q14012; -.
DR   MaxQB; Q14012; -.
DR   PaxDb; Q14012; -.
DR   PeptideAtlas; Q14012; -.
DR   PRIDE; Q14012; -.
DR   TopDownProteomics; Q14012; -.
DR   DNASU; 8536; -.
DR   Ensembl; ENST00000256460; ENSP00000256460; ENSG00000134072.
DR   GeneID; 8536; -.
DR   KEGG; hsa:8536; -.
DR   UCSC; uc003bst.4; human.
DR   CTD; 8536; -.
DR   DisGeNET; 8536; -.
DR   GeneCards; CAMK1; -.
DR   HGNC; HGNC:1459; CAMK1.
DR   HPA; CAB031904; -.
DR   HPA; HPA051409; -.
DR   MIM; 604998; gene.
DR   neXtProt; NX_Q14012; -.
DR   OpenTargets; ENSG00000134072; -.
DR   PharmGKB; PA26048; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   eggNOG; ENOG410XRMJ; LUCA.
DR   GeneTree; ENSGT00760000118944; -.
DR   HOGENOM; HOG000233016; -.
DR   HOVERGEN; HBG108055; -.
DR   InParanoid; Q14012; -.
DR   KO; K08794; -.
DR   OMA; VTVEKRY; -.
DR   OrthoDB; EOG091G0HK9; -.
DR   PhylomeDB; Q14012; -.
DR   TreeFam; TF314166; -.
DR   BRENDA; 2.7.11.17; 2681.
DR   SignaLink; Q14012; -.
DR   SIGNOR; Q14012; -.
DR   GeneWiki; CAMK1; -.
DR   GenomeRNAi; 8536; -.
DR   PRO; PR:Q14012; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000134072; -.
DR   CleanEx; HS_CAMK1; -.
DR   ExpressionAtlas; Q14012; baseline and differential.
DR   Genevisible; Q14012; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005622; C:intracellular; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB.
DR   GO; GO:0006913; P:nucleocytoplasmic transport; IEA:Ensembl.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IBA:GO_Central.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IMP:UniProtKB.
DR   GO; GO:0051149; P:positive regulation of muscle cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:UniProtKB.
DR   GO; GO:1901985; P:positive regulation of protein acetylation; IMP:UniProtKB.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; IDA:UniProtKB.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0051835; P:positive regulation of synapse structural plasticity; IMP:UniProtKB.
DR   GO; GO:0060143; P:positive regulation of syncytium formation by plasma membrane fusion; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0051147; P:regulation of muscle cell differentiation; IDA:UniProtKB.
DR   GO; GO:0043393; P:regulation of protein binding; IDA:UniProtKB.
DR   GO; GO:0032880; P:regulation of protein localization; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR020636; Ca/CaM-dep_Ca-dep_prot_Kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347; PTHR24347; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; ATP-binding; Calmodulin-binding;
KW   Cell cycle; Complete proteome; Cytoplasm; Developmental protein;
KW   Differentiation; Direct protein sequencing; Isopeptide bond; Kinase;
KW   Neurogenesis; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Ubl conjugation.
FT   CHAIN         1    370       Calcium/calmodulin-dependent protein
FT                                kinase type 1.
FT                                /FTId=PRO_0000086076.
FT   DOMAIN       20    276       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      26     34       ATP.
FT   REGION      276    316       Autoinhibitory domain.
FT   REGION      296    317       Calmodulin-binding. {ECO:0000250}.
FT   MOTIF       315    321       Nuclear export signal. {ECO:0000250}.
FT   ACT_SITE    141    141       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      49     49       ATP.
FT   MOD_RES     177    177       Phosphothreonine; by CaMKK1 and CaMKK2.
FT                                {ECO:0000269|PubMed:7641687}.
FT   MOD_RES     363    363       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CROSSLNK     59     59       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000305|PubMed:23707388}.
FT   VARIANT     217    217       P -> S (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040596.
FT   VARIANT     361    361       E -> K (in dbSNP:rs56033923).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040597.
FT   MUTAGEN      49     49       K->A: Catalytically inactive form;
FT                                prevents CDK4 activation.
FT                                {ECO:0000269|PubMed:14754892,
FT                                ECO:0000269|PubMed:7641687}.
FT   MUTAGEN     177    177       T->A: Loss of activation by CaMKK1.
FT                                {ECO:0000269|PubMed:7641687}.
FT   MUTAGEN     177    177       T->D: Partial activation in absence of
FT                                CaMKK1. {ECO:0000269|PubMed:7641687}.
FT   HELIX        16     18       {ECO:0000244|PDB:4FG8}.
FT   STRAND       20     29       {ECO:0000244|PDB:4FG8}.
FT   STRAND       32     39       {ECO:0000244|PDB:4FG8}.
FT   TURN         40     42       {ECO:0000244|PDB:4FG8}.
FT   STRAND       45     52       {ECO:0000244|PDB:4FG8}.
FT   HELIX        66     70       {ECO:0000244|PDB:4FG8}.
FT   STRAND       81     86       {ECO:0000244|PDB:4FG8}.
FT   STRAND       88     95       {ECO:0000244|PDB:4FG8}.
FT   STRAND      100    102       {ECO:0000244|PDB:4FG9}.
FT   HELIX       103    109       {ECO:0000244|PDB:4FG8}.
FT   HELIX       115    134       {ECO:0000244|PDB:4FG8}.
FT   HELIX       144    146       {ECO:0000244|PDB:4FG8}.
FT   STRAND      147    152       {ECO:0000244|PDB:4FG8}.
FT   STRAND      158    160       {ECO:0000244|PDB:4FG8}.
FT   HELIX       166    168       {ECO:0000244|PDB:4FGB}.
FT   HELIX       173    178       {ECO:0000244|PDB:4FG8}.
FT   TURN        182    184       {ECO:0000244|PDB:4FG8}.
FT   HELIX       187    190       {ECO:0000244|PDB:4FG8}.
FT   HELIX       198    213       {ECO:0000244|PDB:4FG8}.
FT   HELIX       223    232       {ECO:0000244|PDB:4FG8}.
FT   TURN        239    244       {ECO:0000244|PDB:4FG8}.
FT   HELIX       247    256       {ECO:0000244|PDB:4FG8}.
FT   TURN        261    263       {ECO:0000244|PDB:4FG8}.
FT   HELIX       267    272       {ECO:0000244|PDB:4FG8}.
FT   HELIX       274    277       {ECO:0000244|PDB:4FG8}.
FT   HELIX       287    297       {ECO:0000244|PDB:4FG8}.
FT   HELIX       301    311       {ECO:0000244|PDB:4FG9}.
SQ   SEQUENCE   370 AA;  41337 MW;  57FA20ECE00FA76C CRC64;
     MLGAVEGPRW KQAEDIRDIY DFRDVLGTGA FSEVILAEDK RTQKLVAIKC IAKEALEGKE
     GSMENEIAVL HKIKHPNIVA LDDIYESGGH LYLIMQLVSG GELFDRIVEK GFYTERDASR
     LIFQVLDAVK YLHDLGIVHR DLKPENLLYY SLDEDSKIMI SDFGLSKMED PGSVLSTACG
     TPGYVAPEVL AQKPYSKAVD CWSIGVIAYI LLCGYPPFYD ENDAKLFEQI LKAEYEFDSP
     YWDDISDSAK DFIRHLMEKD PEKRFTCEQA LQHPWIAGDT ALDKNIHQSV SEQIKKNFAK
     SKWKQAFNAT AVVRHMRKLQ LGTSQEGQGQ TASHGELLTP VAGGPAAGCC CRDCCVEPGT
     ELSPTLPHQL
//
